Icrucumab
Icrucumab Uses, Dosage, Side Effects, Food Interaction and all others data.
Icrucumab is under investigation in clinical trial NCT01111604 (A Study of IMC-1121B or IMC-18F1 in Colorectal Cancer).
| Trade Name | Icrucumab |
| Generic | Icrucumab |
| Icrucumab Other Names | Icrucumab, IMC-18F1 |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Icrucumab
